×
About 11,939 results

ALLMedicine™ Platelet Aggregation Center

Research & Reviews  5,845 results

Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation.
https://doi.org/10.1055/s-0041-1728831
Seminars in Thrombosis and Hemostasis; Limami Y, Khalki L et. al.

May 10th, 2021 - Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation.|2021|Limami Y,Khalki L,Zaid N,Khyatti M,Turk JE,|

Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y12 receptor bet...
https://doi.org/10.1002/psp4.12641
CPT: Pharmacometrics & Systems Pharmacology; Henrich A, Claussen CH et. al.

May 6th, 2021 - Selatogrel is a potent and reversible P2Y12 receptor antagonist developed for subcutaneous self-administration by patients with suspected acute myocardial infarction. After single-dose emergency treatment with selatogrel, patients are switched to ...

Brazilian propolis (AF-08) inhibits collagen-induced platelet aggregation without affec...
https://doi.org/10.1007/s11418-021-01518-w
Journal of Natural Medicines; Sugita C, Yamashita A et. al.

May 4th, 2021 - Brazilian propolis (AF-08) is a dietary supplement containing a variety of flavonoids. It is used worldwide as a folk medicine. Flavonoids and a diet of fruits and vegetables containing them have been shown to reduce the risk of cardiovascular dis...

ADP-induced platelet reactivity and bleeding events in patients with acute myocardial i...
https://doi.org/10.1080/09537104.2021.1913577
Platelets Scherer C, Lüsebrink E et. al.

May 4th, 2021 - While previous reports showed ADP-induced platelet reactivity to be an independent predictor of bleeding after PCI in stable patients, this has never been investigated in patients with cardiogenic shock. The association of bleeding events with res...

see more →

Guidelines  1 results

Prophylaxis and management of venous thromboembolism in patients with myeloproliferativ...
https://doi.org/10.1007/s00277-014-2224-8
Annals of Hematology; Kreher S, Ochsenreither S et. al.

Oct 13th, 2014 - Patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) like polycythemia vera and essential thrombocythemia are at increased risk of arterial and venous thrombosis. Strategies of prevention may consist of platelet aggreg...

see more →

Drugs  41 results see all →

Clinicaltrials.gov  5,951 results

Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation.
https://doi.org/10.1055/s-0041-1728831
Seminars in Thrombosis and Hemostasis; Limami Y, Khalki L et. al.

May 10th, 2021 - Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation.|2021|Limami Y,Khalki L,Zaid N,Khyatti M,Turk JE,|

Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y12 receptor bet...
https://doi.org/10.1002/psp4.12641
CPT: Pharmacometrics & Systems Pharmacology; Henrich A, Claussen CH et. al.

May 6th, 2021 - Selatogrel is a potent and reversible P2Y12 receptor antagonist developed for subcutaneous self-administration by patients with suspected acute myocardial infarction. After single-dose emergency treatment with selatogrel, patients are switched to ...

Brazilian propolis (AF-08) inhibits collagen-induced platelet aggregation without affec...
https://doi.org/10.1007/s11418-021-01518-w
Journal of Natural Medicines; Sugita C, Yamashita A et. al.

May 4th, 2021 - Brazilian propolis (AF-08) is a dietary supplement containing a variety of flavonoids. It is used worldwide as a folk medicine. Flavonoids and a diet of fruits and vegetables containing them have been shown to reduce the risk of cardiovascular dis...

ADP-induced platelet reactivity and bleeding events in patients with acute myocardial i...
https://doi.org/10.1080/09537104.2021.1913577
Platelets Scherer C, Lüsebrink E et. al.

May 4th, 2021 - While previous reports showed ADP-induced platelet reactivity to be an independent predictor of bleeding after PCI in stable patients, this has never been investigated in patients with cardiogenic shock. The association of bleeding events with res...

see more →

News  101 results

Chewed Prasugrel for Primary PCI? Forget It!
https://www.medscape.com/viewarticle/933404

Jul 2nd, 2020 - Tirofiban is far superior to cangrelor at achieving rapid and potent inhibition of platelet aggregation in patients undergoing primary percutaneous coronary intervention for ST-elevation MI. And cangrelor, in turn, is superior to oral prasugrel, a...

Chewed Prasugrel for Primary PCI? Forget It!
https://www.staging.medscape.com/viewarticle/933404

Jul 2nd, 2020 - Tirofiban is far superior to cangrelor at achieving rapid and potent inhibition of platelet aggregation in patients undergoing primary percutaneous coronary intervention for ST-elevation MI. And cangrelor, in turn, is superior to oral prasugrel, a...

Clopidogrel Appropriate for PCI in Liver Transplant Candidates
https://www.medscape.com/viewarticle/923457

Jan 7th, 2020 - NEW YORK (Reuters Health) - In patients with decompensated cirrhosis undergoing percutaneous coronary intervention (PCI), clopidogrel safely inhibits platelet aggregation, according to a small study of liver-transplant candidates. "Patients with a...

Clopidogrel Appropriate for PCI in Liver Transplant Candidates
https://www.staging.medscape.com/viewarticle/923457

Jan 7th, 2020 - NEW YORK (Reuters Health) - In patients with decompensated cirrhosis undergoing percutaneous coronary intervention (PCI), clopidogrel safely inhibits platelet aggregation, according to a small study of liver-transplant candidates. "Patients with a...

Novel Antiplatelet Agent May Not Increase Bleeding Risk
https://www.staging.medscape.com/viewarticle/911977

Apr 17th, 2019 - A new approach to inhibiting platelets that may separate the antithrombotic effect from the bleeding risk has shown promising preliminary results, raising the hope of developing an agent for the treatment of acute ischemic stroke that can inhibit ...

see more →